Skip to main content

Duke-UNC ADRC announces three research funding opportunities

November 10, 2021

The Duke/UNC ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and UNC studying Alzheimer’s disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from UNC Pembroke, North Carolina Central University, and East Carolina University.

UNC Neurology Receives New Center of Excellence Designation

September 1, 2021

The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.

Aducanumab Update

July 15, 2021

Learn about aducanumab and UNC Neurology’s position on the new drug approved by the FDA for Alzheimer’s disease.

Almodóvar-Suárez Named Director of ALS Clinic

June 25, 2021

Jorge L. Almodóvar-Suárez, MD, associate professor of general neurology and neuromuscular disorders, is the new director of the UNC Department of Neurology’s Amyotrophic Lateral Sclerosis (ALS) Clinic. Born and raised in Puerto Rico, Dr. Almodóvar-Suárez is graduate of the state-funded University of Puerto Rico System, and a faithful believer of education and health care for … Continued